Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cachovan

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
British Journal of Clinical Pharmacology|January 1, 1979
Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertensionJ Bahlmann, J Brod, W Hubrich, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1975
[Programmed medical letters in angiology]H G Jester, G Imhof, T Wuppermann, et al.
Wiener Klinische Wochenschrift|January 1, 1994
[The effectiveness of standardized exercise training in intermittent claudication]M Cachovan, P Scheffler, J Gruss, et al.
British Journal of Clinical Pharmacology|December 5, 2015
Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertensionJ Bahlmann, J Brod, W Hubrich, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1995
Guidelines for therapeutic studies in Fontaine's stages II-IV peripheral arterial occlusive disease. German Society of AngiologyH Heidrich, M Cachovan, A Creutzig, et al.
Klinische Wochenschrift|July 15, 1980
[Pathogenesis of renal hypertension (author's transl)]J Brod, J Bahlmann, M Cachovan, et al.
Nephron|January 1, 1980
Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal diseaseJ Brod, J Bahlmann, M Cachovan, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Clinical and haemodynamic study of a new vasodilator drug L6150 (3-[bis-(2-hydroxyethyl)amino]-6-hydrazinopyridazine) in manJ Brod, J Bahlmann, M Cachovan, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1982
Mechanisms for the elevation of blood pressure in human renal disease. Preliminary reportJ Brod, J Bahlmann, M Cachovan, et al.
VASA. Supplementum|January 1, 1992
[Assessment of the clinical effectiveness of actihaemyl in Fontaine stage IIb intermittent claudication]S Horsch, L Claeys, C Diehm, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|January 1, 1979
Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertensionJ Bahlmann, J Brod, W Hubrich, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1975
[Programmed medical letters in angiology]H G Jester, G Imhof, T Wuppermann, et al.
Wiener Klinische Wochenschrift|January 1, 1994
[The effectiveness of standardized exercise training in intermittent claudication]M Cachovan, P Scheffler, J Gruss, et al.
British Journal of Clinical Pharmacology|December 5, 2015
Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertensionJ Bahlmann, J Brod, W Hubrich, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1995
Guidelines for therapeutic studies in Fontaine's stages II-IV peripheral arterial occlusive disease. German Society of AngiologyH Heidrich, M Cachovan, A Creutzig, et al.
Klinische Wochenschrift|July 15, 1980
[Pathogenesis of renal hypertension (author's transl)]J Brod, J Bahlmann, M Cachovan, et al.
Nephron|January 1, 1980
Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal diseaseJ Brod, J Bahlmann, M Cachovan, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Clinical and haemodynamic study of a new vasodilator drug L6150 (3-[bis-(2-hydroxyethyl)amino]-6-hydrazinopyridazine) in manJ Brod, J Bahlmann, M Cachovan, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1982
Mechanisms for the elevation of blood pressure in human renal disease. Preliminary reportJ Brod, J Bahlmann, M Cachovan, et al.
VASA. Supplementum|January 1, 1992
[Assessment of the clinical effectiveness of actihaemyl in Fontaine stage IIb intermittent claudication]S Horsch, L Claeys, C Diehm, et al.
Pageof 5